相关实验视频
Updated: Jul 27, 2025

06:47
A Murine Model of Vertical Sleeve Gastrectomy
Published on: December 18, 2017
11.2K
禁食患者在麻醉下反,为减肥处方西马格卢提德:一个病例报告
Michael A Gulak1, Patricia Murphy2
1Department of Anesthesiology and Pain Medicine, University of Toronto, 12th Floor, 123 Edward Street, Toronto, ON, M5G 1E2, Canada. mike.gulak@mail.utoronto.ca.
概括
服用类似葡萄糖类-1受体激动剂 (GLP-1RA) 的患者,如塞马格卢提德,在麻醉期间可能面临吸收风险. 在手术前四周停止使用GLP-1RA,并采取全胃预防措施以减轻风险.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
背景情况:
- 类似葡萄糖类-1受体激动剂 (GLP-1RA),包括黄,用于治疗2型糖尿病和减肥.
- 这些药物延迟了胃空气,抑制了食欲,而塞马格卢提德的半衰期长,大约为一周.
- 目前还没有关于GLP-1RA的外科治疗指南.
研究的目的:
- 突出在麻醉下接受GLP-1RA的患者肺吸收的潜在风险.
- 在没有传统风险因素的患者身上展示这种风险的案例.
主要方法:
- 一个病人的病例报告在麻醉诱导期间经历了反.
- 审查患者的药物 anamnesis,包括semaglutide的使用.
- 对手术前禁食协议和麻醉管理的分析.
主要成果:
- 尽管固体禁食20小时,但发生了意想不到的大体积反.
- 患者正在服用西马格卢提德来减肥,并且在手术前两天服用了最后一剂.
- 这一事件表明GLP-1RA对胃空化的长时间影响.
结论:
- 服用长效GLP-1RA药物 (如西马格卢提德) 的患者在麻醉期间有肺吸气的风险.
- 建议包括在可能的情况下在选择性手术前四周停止服用药物.
- 建议在服用这些药物的患者考虑全胃预防措施.
相关概念视频
Glucagon-like Receptor Agonists
370
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
370
Hypoglycemia and Glucagon
306
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
306
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
128
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
128
Gastric Emptying
977
Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
977
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
210
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
210
Endoscopic Procedures I: Esophagogastroduodenoscopy
222
An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
During an EGD, the endoscope can be used to:
222

